Clinical Trial Update: A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 multicenter, randomized, double-blind, placebo-controlled trial completed to assess the efficacy and safety of donepezil hydrochloride in Chinese pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Limited | Conditions: Alzheimer's Type Dementia | Phase 3 | Status: COMPLETED